Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Receivables: 2023-2024

Historic Receivables for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $397,000.

  • Inhibrx Biosciences' Receivables rose 24.55% to $837,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $397,000 for FY2024, which is 71.34% down from last year.
  • Inhibrx Biosciences' Receivables amounted to $397,000 in FY2024, which was down 71.34% from $1.4 million recorded in FY2023.
  • Over the past 5 years, Inhibrx Biosciences' Receivables peaked at $1.4 million during FY2023, and registered a low of $397,000 during FY2024.
  • For the 2-year period, Inhibrx Biosciences' Receivables averaged around $891,000, with its median value being $891,000 (2023).
  • Data for Inhibrx Biosciences' Receivables shows a maximum YoY slumped of 71.34% (in 2024) over the last 5 years.
  • Inhibrx Biosciences' Receivables (Yearly) stood at $1.4 million in 2023, then plummeted by 71.34% to $397,000 in 2024.